This Little Med-Device Went to Market: Health Economics & Market Access

Add this event to your calendar:
15/11/2016 12:00 15/11/2016 14:00 America/Toronto This Little Med-Device Went to Market: Health Economics & Market Access JLABS @ Toronto , 661 University Ave , Toronto , ON M5G 1M1 JLABS @ Toronto false DD/MM/YYYY
November
15
Event

This Little Med-Device Went to Market: Health Economics & Market Access

JLABS @ Toronto , 661 University Ave , Toronto , ON M5G 1M1

November 15, 2016 from 12:00 PM to 14:00 PM (EDT)

$10 - $35


"Well begun is half done" – Aristotle
Clearly, Aristotle never worked to bring an innovative medical device to market.

The sooner you start thinking about how your product will delight clinical AND non-clinical customers, the more likely you are to optimize the market access and patient access that is critical to your success.

Beyond the challenges associated with gaining regulatory approval, there are hurdles to overcome as you enter the real world with your innovation. Many of these challenges can be addressed through understanding the non-clinical and clinical situation, building integrated plans for evidence to quantify and communicate the value of your solution, and market access & reimbursement strategies to ensure access and adoption.

On November 15, Brian, Diane and Trisha will discuss today's market access landscape for medical devices and how to ensure you are starting early with a plan to succeed. Don't miss the opportunity to apply for a one-on-one meeting with these experts as a forum to further discuss your company and personal reimbursement path.


Agenda:
11:00am | Registration Opens
11:30am | Presentations
12:15pm | Q&A
12:30pm | Lunch & Networking
1:30pm | Program Close
1:30-5:00pm | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and been approved. In your application, be sure to describe potential market access (reimbursement, pricing, etc.) barriers or opportunities you have identified. The application period has ended.


Speakers
Brian Vaughn | Leader - Global Health Economics & Market Access, Ethicon read bio»
Diane Francis | Senior Director, US Health Economics and Market Access, Ethicon read bio»
Trisha Hutzul | Senior Director, Global Health Economics and Market Access, Johnson & Johnson MD&D read bio»


Event Partner
ventureLAB


Fees:
Presentation & Lunch
CA$ 40  | General Public
CA$ 30  | Student/Academic
CA$ 55  | At the door
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until noon on November 14th, 2016 (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. In your application, be sure to describe potential market access (reimbursment, pricing, etc.) barriers or opportunities you have identified. The one-on-one application has ended. Your application will be reviewed and you will be notified of acceptance by email on November 10th, 2016. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.


Location:
JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario


Speakers' Biographies:

Brian Vaughn | Leader - Global Health Economics & Market Access, Ethicon, Inc.
Brian has worked in the business of healthcare for over 25 years and is currently the Leader of Global Health Economics and Market Access at ETHICON Inc.. Brian and his Team are responsible for developing and executing integrated market access, health economic and outcomes research strategies across all stages of the product life cycle. Brian is passionate about innovation and enjoys helping to quantify, communicate and capture the value of innovative technologies to ensure that they are accessible to the patients that will benefit most from their successful launch and adoption. His responsibilities include helping to shape the innovation strategy, market access assessment, strategy & execution, optimization of non-clinical value propositions, life cycle evidence of value strategies and informing strategic pricing. Since joining Johnson and Johnson in 1999 Brian has worked extensively in the US and globally. His experience spans the range of HEMA strategy and tactics with focus on health economics, outcomes research, reimbursement and market access. He has worked in numerous surgical specialties including minimally invasive cardiac surgery, aesthetic & reconstructive plastic surgery, women's health, orthopedics & sports medicine, metabolics & bariatrics and general surgery. His areas of product/technology focus have included wound management, wound closure, advanced energy and endo-mechanical surgical devices. Prior to Joining Johnson & Johnson Brian worked in Managed Care in the Metro New York Market. Brian held a number of leadership roles in Medical Delivery Systems building and managing delivery networks and leading Teams responsible for hospital and health systems contracting. Brian has an MPA in Healthcare Policy and Management and an MBA in Marketing. Throughout his career Brian has shown passion for leadership, working with Teams and helping the people around him to achieve their personal and professional goals.
Connect with Brian:   Connect on LinkedIn



Diane M. Francis, MPH | Senior Director, US Health Economics and Market Access, Ethicon US, LLC
Diane Francis has more than 25 years of diverse experience in community development, hospital administration and medical device market access. Prior to joining Johnson & Johnson, Diane led a variety of community health and managed care initiatives. She founded a non-profit organization that focuses on economic literacy and empowerment. She also established and then served as CEO of a NJ physician-hospital organization (PHO) providing managed care contracting and revenue cycle management services. In 2000, Diane joined Johnson & Johnson, where she has specialized in health economic, reimbursement, and evidence strategies for medical devices, from product concept through commercialization. She has served in supported a variety of businesses and held positions of increase responsibility. Currently, Diane is Senior Director of Health Economic and Market Access at ETHICON for the U.S. There she leads a team that delivers innovative health economic solutions that enhance product and business competitiveness in the evolving value-based health care system. Recently, one of her innovative economic solutions was recognized by an innovation award. She holds a Bachelors of Arts from Cornell University and Masters of Public Health from Columbia University.
Connect with Diane:   Connect on LinkedIn



Trisha Hutzul | Senior Director Global Health Economics and Market Access, Johnson & Johnson MD&D
Trisha Hutzul currently functions as the Global Transformation Lead for the Johnson and Johnson Health Economics and Market Access Center of Excellence. In this role she is responsible for working across the Research and Development (R&D) organization to identify synergies and interdependencies with partners from R&D, clinical, medical, regulatory and supply chain. Prior to this recent posting, Trisha worked as the Senior Director of Surgical Innovation (HEMA) for the medical device division of Ethicon. In this role she was responsible for leading a team dedicated to the creation of strategic market access plans and evidence of value. Her scope included front end strategy development and support of external early innovation. Trisha is a Graduate of the University of Toronto and the Johns Hopkins School of Public Health, Medical Institutes. She entered the pharmaceutical industry 15 years ago as an Intern Scientist and has held positions of increasing responsibility across both the pharmaceutical and device sectors ever since. Her work has spanned market access, professional medical education and health care policy. Prior to joining the Johnson and Johnson Global team in 2013, Trisha held the position of Medical Affairs Director Johnson and Johnson Medical Companies Canada. In this position she was responsible for the development of the local research and medical education plans. Trisha has held positions that have supported research in both the developed and developing markets, and past work has included the development of emerging markets access plans to support early adoption and lifecycle management in BRIC (Brazil , Russia, India and China. Trisha has a passion for innovation, and is currently enrolled in the Kellogg Executive Scholars Program Northwestern University. She is also and mentor and sponsor of cross sector talent development.
Connect with Trisha:   Connect on LinkedIn


JLABS @ Toronto

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

Event contact


Related content